An Australian stem cell and regenerative medicine company
About Us
About Us
What We Do
Board Of Directors
Management
Scientific Advisors
Corporate Governance
Company History
Clinical Development
Graft-versus-host-disease
Osteoarthritis
Acute respiratory distress syndrome
Diabetic Wounds
Renal transplantation
Pre-clinical Development
Asthma
Heart Attack
Coronary Artery Disease
Brain Cancer
Sepsis
Critical Limb Ischemia
Idiopathic pulmonary fibrosis
Science & Technology
Cymerus Technology
About MSCs
About iPSCs
Science Publications
Investors
Stock Information
ASX Announcements
Financial Reports
Presentations
Corporate Governance
Analyst Research
Investor FAQs
Right to Receive Documents
Newsroom
FAQ
Company FAQs
Investor FAQs
Contact Us
ASX Announcements
10 Nov 2015
Results of Annual General Meeting
05 Nov 2015
Restricted Securities to be Released from Escrow
04 Nov 2015
Cynata Engages CRO to Conduct GvHD Clinical Trial
13 Oct 2015
CYP in Major New Collaboration for Cell Therapy for Cancer
05 Oct 2015
Notice of Annual General Meetin/Proxy Form
06 Sep 2015
Cynata to Present at Rodman & Renshaw Investment Conference
02 Sep 2015
SeeThruEquity Initiates Cynata Research Coverage
20 Aug 2015
Appendix 4G
29 Jul 2015
Cynata in Heart Disease Collaboration with Uni of Sydney
16 Jul 2015
Information Required Under Listing Rule 3.10.5A
16 Jul 2015
Appendix 3B
14 Jul 2015
Section 708A Notice
14 Jul 2015
Private Placement to US Institutional Investors Completed
24 May 2015
R&D Tax Incentive
20 May 2015
Cynata-Cymerus Progress Report
07 May 2015
ASX Price Query
29 Mar 2015
Appendix 3Y-John Chiplin
17 Mar 2015
Cynata CEO to Chair World Congress Session on Stem Cells
15 Mar 2015
Appendix 3Y-Stewart Washer
15 Mar 2015
Executive Services Contracts Renewed/Vesting Conditions Met
11 Mar 2015
Commences Further Stage of Stem Cell Manufacturing Program
05 Mar 2015
Director Options Vesting Condition Met
04 Mar 2015
Cynata Presenting at 8th Annual ASX Spotlight New York 2015
19 Feb 2015
BBY Updates Cynata Research Coverage
18 Feb 2015
Cynata Achieves Major Stem Cell Manufacturing Milestone
16 Feb 2015
Trading Halt
15 Feb 2015
Cynata Engages CRO to Plan Clinical Trial
12 Feb 2015
Change of Share Registry
11 Feb 2015
Cynata Engages Leading US Investor Relations Firm
02 Feb 2015
Cynata Partners with University of Western Australia
14 Jan 2015
Top 20 Shareholders
13 Jan 2015
Section 708A Notice
13 Jan 2015
Appendix 3B
05 Jan 2015
Section 708A Notice
05 Jan 2015
Completion of Exercise of Underwritten Listed Options
30 Dec 2014
Section 708A Notice
30 Dec 2014
Appendix 3B-Exercise of Listed Options
23 Dec 2014
Section 708A Notice
23 Dec 2014
Appendix 3B-Exercise of Listed Options
17 Dec 2014
Appendix 3Y-Peter Webse
17 Dec 2014
Section 708A Notice
17 Dec 2014
Appendix 3B-Exercise of Listed Options
10 Dec 2014
Section 708A Notice
10 Dec 2014
Appendix 3B-Exercise of Listed Options
04 Dec 2014
Section 708A Notice
04 Dec 2014
Appendix 3B-Exercise of Listed Options
03 Dec 2014
CYP to Present at Major International Stem Cell Conference
30 Nov 2014
Notification of Expiry of Listed Options
24 Nov 2014
Cynata Listed Options Fully Underwritten
23 Nov 2014
Appendix 3B-Release of Shares from Escrow
‹
1
2
3
4
5
6
7
8
9
10
11
›